Preparations of two pivotal intermediates for the synthesis of 1-β-methyl carbapenem antibiotics

Tetrahedron

Volumn 52, Issue 2, 1996, Pages 331-375

  Berks, Andrew H ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1BETA METHYLCARBAPENEM DERIVATIVE; 2 AZETIDINONE DERIVATIVE; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; UNCLASSIFIED DRUG;

DRUG SYNTHESIS; PRIORITY JOURNAL; REACTION ANALYSIS; REVIEW; STEREOCHEMISTRY;

EID: 0030028910     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4020(95)00842-X     Document Type: Review

References (173)

1. Sunagawa, M.; Matsamura, H.; Takaaki, I.; Fukasawa, M.; Kato, M. J. Antibiotics 1990, 43, 519-532.
2. (a) Petersen, P.J.; Jacobus, N.V.; Weiss, W.J.; Testa, R.T. Antimicrob. Agents Chemother. 1991, 35, 203-207.
3. (b) Malonski, G.J.; Collins, L.; Wennerstein, C.; Moellering, R.C.; Eliopoulos, G.M. Antimicrob. Agents Chemother. 1993, 37, 2009-2016.
4. Shih, D.H.; Cama, L.; Christensen, B.G. Tetrahedron Lett. 1985, 26, 587-590.
5. Shih, D.H.; Baker, F.; Cama, L.; Christensen, B.G. Heterocycles 1984, 21, 29-40.
6. (a) Ito, Y.; Terashima, S. Yuki Goseikagaku Kyokai Shi 1989, 47, 606-618.
7. (b) Ito, Y.; Terashima, S. In Studies in Natural Products Chemistry, Vol. 12; Atta-ur-Rahman, Ed.; Elsevier: 1993; pp. 145-177 (Chem. Abstr. 119:203186; this abstract was mis-indexed by Chemical Abstracts, and did not have the Registry number for 2 as an index term, making it difficult to locate).
8. (b) Ito, Y.; Terashima, S. In Studies in Natural Products Chemistry, Vol. 12; Atta-ur-Rahman, Ed.; Elsevier: 1993; pp. 145-177 (Chem. Abstr. 119:203186; this abstract was mis-indexed by Chemical Abstracts, and did not have the Registry number for 2 as an index term, making it difficult to locate).
9. (a) Earliest Literature Ref: Oida, S. Recent Advances in Beta Lactam Antibiotics; Royal Society of Chemistry: London, 1981; pp 330-348.
10. (b) This same work is presented in Yoshida, A.; Hayashi, T.; Takeda, N.; Oida, S.; Ohki, E. Chem. Pharm. Bull. 1981, 29, 2899-2909.
11. (c) Method B is disclosed in Ohki, E.; Oida, S.; Yoshida, A.; Hayashi, T.; Sugawara, S. U.S. Patent US 4395418, Jul. 26, 1983 (Derwent WPI 81-95037D).
12. (a) Hirai, K.; Iwano, Y.; Fujimoto, K. Heterocycles, 1982, 17, 201-207.
13. (b) Fujimoto, K.; Iwano, Y.; Hirai, K.; Sugawara, S. Chem. Pharm. Bull. 1986, 34, 999-1014.
14. Leanza, W.J.; DiNinno, F.; Muthard, D.A.; Wilkening, R.R.; Wildonger, K.J.; Ratcliffe, R.W.; Christensen, B.G. Tetrahedron, 1983, 39, 2505-2513.
15. Goo, Y.M.; Lee, Y.B.; Kim, H.H.; Lee, Y.Y.; Lee, W.Y. Bull. Korean Chem. Soc. 1987, 8, 15-19.
16. (a) Martel, A.; Daris, J.-P.; Bachand, C.; Menard, M. Can. J. Chem. 1987, 65, 2179-2181.
17. (b) Compound claims for 12 and 13: Martel, A.; Daris, J.-P. U.S. Patent US 4639335, Jan. 27, 1987 (Derwent WPI 85-258263).
18. (c) Process claims for 11→12→13: Martel, A.; Daris, J.-P. U.S. Patent US 4596677, Jun. 24, 1986 (Derwent WPI 85-258263).
19. (a) Reider, P.J.; Grabowski, E.J.J. Tetrahedron Lett. 1982, 23, 2293-2296.
20. (b) Grabowski, E.J.J.; Reider, P.J. Eur. Patent Appl. EP 78026, May 4, 1983 (Derwent WPI 83-4632K).
21. For stereospecific reduction of C-3 ethyl ketones to the (R)-alcohol see refs. 12, 17, 19, 71.
22. (a) Mori, M.; Kagechika, K.; Sasai, H.; Shibasaki, M. Tetrahedron 1991, 47, 531-540.
23. (b) Preliminary report: Mori, M.; Kagechika, K.; Tohjima, K.; Shibasaki, M. Tetrahedron Lett. 1988, 29, 1409-1412.
24. (a) Cainelli, G., Contento, M.; Giacomini, D.; Panunzio, M. Tetrahedron Lett. 1985, 26, 937-940.
25. (b) Cainelli, G.; Contento, M.; Giacomini, D.; Panunzio, M.; Franceschi, G. U.K. Patent Appl. GB 2162840, Feb. 12, 1986 (process claims).
26. Georg, G.I.; Kant, J.; Gill, H.S. J. Am. Chem. Soc. 1987, 109, 1129-1135.
27. (a) Chiba, T.; Nakai, T. Chemistry Lett. 1985, 651-654.
28. (b) Chiba, T.; Nagatsuma, M.; Nakai, T. Chemistry Lett. 1985, 1343-1346.
29. (c) Chiba, T.; Nakai, T. Tetrahedron Lett. 1985, 26, 4647-4648.
30. (d) Chiba, T.; Nakai, T. Eur. Patent Appl. EP 171064, Feb. 12, 1986 (Derwent WPI 86-043612).
31. 3, without the use of peroxidic reagents, for the Baeyer-Villiger type oxidation of e.g., 41→1 (cf. Scheme 9) in quantitative yield: Murahashi, S.; Oda, Y. Jap. Patent Appl. JP 06009551, Jan. 18, 1994 (Derwent WPI 94-086056).
32. (a) Ito, Y.; Kobayashi, Y.; Kawabata, T.; Takase, M.; Terashima, S. Tetrahedron 1989, 45, 5767-5790.
33. (b) 46→47: Jap. Patent Appl. JP 01216965, Aug. 30, 1989 (Derwent WPI 89-295763).
34. (c) The Sagami group has also published an alternative method for reducing the C-3 side chain ketone selectively to the (R)-hydroxyethyl (i.e., 52a→53), using an amino alkoxy borane: Jap. Patent Appl. JP 01101084, Apr. 19, 1989 (Derwent WPI 89-160824).
35. (d) Process 54→55: Jap. Patent Appl. JP 0121698, Aug. 30, 1989 (Derwent WPI 89-295765).
36. (e) Process 41→1: Jap. Patent Appl. JP 01246255, Oct. 2, 1989 (Derwent WPI 89-329485).
37. (f) Preparation of 52: Terashima, S. Eur. Patent Appl. EP 271586, Jun. 22, 1986 (Derwent WPI 87-362699).
38. Colombo, M.; Crugnola, A.; Franceschi, G.; Lombardi, P. U.K. Patent Appl. GB 2144419, Mar. 3, 1985 (Derwent WPI 85-038254).
39. (a) Kobayashi, Y.; Ito, Y.; Terashima, S. Tetrahedron, 1992, 48, 55-66.
40. (b) Process 53→54, Jap. Patent Appl. JP 02172985, Jul. 4, 1990 (Derwent WPI 90-249735).
41. (c) Process 59→62, Jap. Patent Appl. JP 02172970, Jul. 4, 1990 (Derwent WPI 90-249731).
42. (a) Nakatsuka, T.; Iwata, H.; Tanaka, R.; Imajo, S.; Ishiguro, M. J. Chem. Soc. Chem. Commun. 1991, 662-664.
43. (b) Patent: Ishiguro, M.; Iwata, H.; Nakatsuka, T.; Yamada, Y. U.S. Patent US 5026844, Jun. 25, 1991 (also Eur. Patent Appl. EP 372699, Jun. 13, 1990; Derwent WPI 90-180500 and 90-171690).
44. (a) Suntory, Ltd. Jap. Patent Appl. JP 06135928, May 17, 1994. (Derwent WPI 94-197055)
45. (b). Suntory, Ltd. Jap. Patent Appl. JP 06135929, May 17, 1994. (Derwent WPI 94-197056).
46. (a) Kita, Y.; Shibata, N.; Miki, T.; Takemura, Y.; Tamura, O. J. Chem. Soc., Chem. Comm. 1990, 727-729.
47. (b) Kita, Y.; Shibata, N.; Yoshida, N.; Tohjo, T. Chem. Pharm. Bull. 1992, 40, 1733-1736.
48. Sunagawa, M.; Matsumua, H.; Enaomoto, M.; Inoue, T.; Sasaki, A. Chem. Pharm. Bull. 1991, 39, 1931-1938.
49. Three related United States Patents (all in Derwent WPI 87-207559): (a) Process claims for 99→1: Ohashi, T.; Kan, K.; Ueyama, N.; Sada, I.; Miyama, A.; Watanabe, K. U.S. Patent US 4861877, Aug. 29, 1989.
50. (b) Compound claims for 99: Ohashi, T.; Kan, K.; Ueyama, N.; Sada, I.; Miyama, A.; Watanabe, K. U.S. Patent US 4791198, Dec. 13, 1988.
51. (c) Compound claims for 98: Ohashi, T.; Kan, K.; Ueyama, N.; Sada, I.; Miyama, A.; Watanabe, K. U.S. Patent US 5061817, Oct. 29, 1991.
52. Related European Patents: (d) Eur. Patent Appl. EP 167154, Jan. 8, 1986 (Derwent WPI 86-009134); Eur. Patent Appl. EP 167155, Jan. 8, 1986 (Derwent WPI 86-009135); Eur. Patent Appl. EP 230248, Jul. 29, 1987 (Derwent WPI 87-207559).
53. (e) Jap. Patent Appl. JP 62195359, Aug. 28, 1987 (Derwent WPI 87-280994).
54. (f) Jap. Patent Appl. JP 62084057, Apr. 17, 1987 (Derwent WPI 87-146837).
55. (g) Eur. Patent Appl. EP 280962, Sep. 7, 1988 (Derwent WPI 88-251568).
56. (h) Eur. Patent Appl. EP 247378, Dec. 2, 1987 (Derwent WPI 87-336102).
57. (i) Process claims for 100→1: Kan, K.; Ueyama, N.; Sada, I.; Ohashi, T.; Watanabe, K. Eur. Patent Appl. EP 247378, Dec. 2, 1987 (also U.S. Patent US 4914200, Apr. 3, 1990; Derwent WPI 87-336102).
58. (j) Compound claims for 100: Jap. Patent Appl. JP 02076888, Mar. 14, 1990 (Derwent WPI 90-128349).
59. (a) Shiozaki, M.; Ishida, N.; Maruyama, H.; Hiraoka, T. Tetrahedron 1983, 39, 2399-2407.
60. (b) Shiozaki, M.; Ishida, N.; Hiraoka, T.; Maruyama, H. Tetrahedron 1984, 40, 1795-1802.
61. (c) Maruyama, H.; Shiozaki, M.; Hiraoka, T. Chem. Pharm. Bull. 1985, 58, 3264-3270.
62. Nippon Soda KK, Jap. Patent Appl. JP 03223246, Oct. 2, 1991 (Derwent WPI 91-335113).
63. The chemistry of Sankyo from Scheme 16 is also disclosed in the Japanese patent literature, (a) Structures 103 and 106: Jap. Patent Appl. JP 63045250, Feb. 26, 1988 (Derwent WPI 88-095019).
64. (b) Process for 102→103: Jap. Patent Appl. JP 56142259, June 11, 1981 (Derwent WPI 81-93778D).
65. (c) Process for 45→105 and 109→1: Jap. Patent Appl. JP 63045251, Feb. 26, 1988 (Derwent WPI 88-095020).
66. (d) Process for 110→112: Jap. Patent Appl. JP 60051171, Mar. 3, 1985 (Derwent WPI 85-107396).
67. Hanessian, S.J.; Bedeschi, A.; Battistini, C.; Mongelli, N. J. Am. Chem. Soc. 1985, 107, 1438-1439.
68. Nippon Soda KK, Jap. Patent Appl. JP 01294661, Nov. 28, 1989 (Derwent WPI 90-012986).
69. Bonini, C.; Di Fabio, R. Tetrahedron Lett. 1988, 29, 815-818.
70. (a) Noyori, R.; Ikeda, T.; Ohkuma, T.; Widhalm, M.; Kitamura, M.; Takaya, H.; Akutagawa, S.; Sayo, N.; Asito, T.; Taketomi, T.; Kumobayashi, H. J. Am. Chem. Soc. 1989, 111, 9134-9135.
71. (b) Murahashi, S.-I.; Naota, T.; Kuwabara, T.; Saito, T.; Kumobayashi, H.; Akutagawa, S. J. Am. Chem. Soc. 1990, 112, 7820-7822.
72. (c) Sayo, N.; Saito, T.; Okeda, Y.; Nagashima, H.; Kumobayashi, H. U.S. Patent US 4981992, Jan. 1, 1991 (also Eur. Patent Appl. EP 369691, May 23, 1990; Derwent WPI 90-157787).
73. (d) Saito, T.; Kumobayashi, H.; Murahashi, S. U.S. Patent US 5288862, Feb. 24, 1994 (also Eur. Patent Appl. EP 509821, Oct. 21, 1992; Derwent WPI 92-351448).
74. (e) The use of assymetric ruthenium catalysts for the transformation of 128 to 1 has also been the subject of a patent: Saito, T.; Kumobayashi, H. Eur. Patent Appl. EP 371875, Jun. 6, 1990 (also U.S. Patent US 5081239, Jan 14, 1992; and U.S. Patent US 5204460, Apr. 20, 1993; Derwent WPI 90-173215).
75. (f) Saito, T.; Kumobayashi, H.; Murahashi, S. Eur. Patent Appl. EP 488611, Jun. 3, 1992 (also U.S. Patent US 5191076, Mar. 2, 1993; Derwent WPI 92-185485).
76. Evans, D.A.; Sjogren, E.B. Tetrahedron Lett. 1986, 27, 4961-4964.
77. Nagao, Y.; Nagase, Y.; Kumagai, T.; Matsunaga, H.; Abe, T.; Shimada, O.; Hayashi, T.; Inoue, Y. J. Org. Chem. 1992, 57, 4243-4249.
78. Jap. Patent Appl. JP 03246274, Nov. 1, 1991 (Derwent WPI 92-027144).
79. Banfi, L.; Guanti, G.; Narisano, E. Tetrahedron 1993, 49, 7385-7392.
80. (a) Lynch, J.E.; Laswell, W.L.; Volante, R.P.; Reamer, R.A.; Tschaen, D.M.; Shinkai, I. Heterocycles 1993, 35, 1029-1037.
81. (b) Compound claims for 154: Lynch, J.E.; Laswell, W.L.; Volante, R.P.; Shinkai, I. Eur. Patent Appl. EP 404586, Dec. 27, 1990 (Derwent WPI 91-001597).
82. (c) Process claims for 154→1 via singlet oxygen: Lynch, J.E.; Laswell, W.L.; Volante, R.P.; Shinkai, I. U.S. Patent US 4940520. Jul. 10, 1990 (Derwent WPI 90-231129).
83. (d) Preparation of 154: Lynch, J.E.; Laswell, W.L.; Volante, R.P.; Shinkai, I. U.S. Patent US 4952288, Aug. 28, 1990 (Derwent WPI 90-282049).
84. (e) Process claims for 154→1 via electrochemical reduction: Lynch, J.E.; Volante, R.P.; Laswell, W.L.; Shinkai, I. U.S. Patent US 4952288, Aug. 28, 1990 (Derwent WPI 90-282049).
85. Nagao, Y.; Nagase, Y.; Kumagai, T.; Kuramoto, Y.; Kobayashi, S.; Inoue, Y.; Taga, T.; Ikeda, H. J. Org. Chem. 1992, 57, 4238-4242.
86. 160 is adapted from refs. 48a and 35.
87. (a) Iwasaki, T.; Kondo, K. Eur. Patent Appl. EP 597423, May 18, 1994 (Derwent WPI 94-160466).
88. (b) Kondo, K.; Seki, M.; Kuroda, T.; Yamanaka, T.; Iwasaki, T. J. Org. Chem. 1995, 60, 1096-1097.
89. Jap. Patent Appl. JP 06065195, Mar. 8, 1994 (Derwent WPI 94-115172).
90. (a) Ito, Y.; Sasaki, A.; Tamoto, K.; Sunagawa, M.; Terashima, S. Tetrahedron, 1991, 47, 2801-2820.
91. (b) Preliminary reports: Ito, Y.; Kobayashi, Y.; Terashima, S. Tetrahedron Lett., 1989, 30, 5631-5634;
92. and (c) Ito, Y.; Terashima, S. Tetrahedron Lett., 1987, 28, 6625-6628.
93. Patents: process claims, (d) Terashima, S.; Ito, Y.; Sakai, K.; Hiyama, T.; Kimura, Y.; Sunagawa, M.; Tamoto, K.; Sasaki, A. U.S. Patent US 5231179, Jul. 27, 1993 (see also EP 232786 Aug. 19, 1987) (Derwent WPI 87-229617).
94. (f) Jap. Patent Appl. JP 63188662, Aug. 4, 1988 (Derwent WPI 88-260509).
95. (f) Jap. Patent Appl. JP 62158277, Jul. 14, 1987 (Derwent WPI 87-232820).
96. (g) Jap. Patent Appl. JP 63010765, Jan. 18 1988 (Derwent WPI 88-053933).
97. (a) see ref. 21.
98. (b) Patent: Jap. Patent Appl. JP 02172987, Jul. 4, 1990 (Derwent WPI 90-249737).
99. (a) see ref. 35
100. (b) Nagao, Y.; Kumagai, T.; Tamai, S.; et al. J. Am. Chem. Soc., 1986, 108, 4673-4675.
101. (c) Patents: Process claims, Nagao, Y.; Kumagai, T.; Tamai, S.; Kuramoto, Y.; Shimidzu, H. U.S. Patent U.S. 491818 4, Apr. 17, 1990 (also Eur. Patent Appl. EP 213610, Mar. 11, 1987; Derwent WPI 87-066327).
102. Déziel, R.; Favreau, D. Tetrahedron Lett. 1986, 27, 5687-5690.
103. (a) Shirai, F J.; Nakai, T. J. Org. Chem. 1987, 52, 5491-5492.
104. (b) Patents: Process claims, Nakai, T.; Shirai, F.; Chiba, T.; Ohtake, H. U.S. Patent US 5075437, Dec. 24, 1991 (Derwent WPI 87-279240).
105. (c) Eur. Patent Appl. EP 239853, Oct. 7, 1987 (Fujisawa) (Derwent WPI 87-279240).
106. (a) Fuentes, L.M.; Shinkai, I.; Salzmann, T.N. J. Am. Chem. Soc. 1986, 108, 4675-4676.
107. (b) Patents: Compound claims to i, Salzmann, T.N.; Fuentes, L.M.; Shinkai, I. U.S. Patent US 4791207, Dec. 13, 1988 (Derwent WPI 89-007557);
108. (c) Compound claims to ii, Salzmann, T.N.; Fuentes, L.M.; Shinkai, I. U.S. Patent US 5104984, Apr. 14, 1992 (Derwent WPI 92-150251);
109. (d) see also European Patent EP 197432, Oct. 15, 1986 Derwent WPI 86-273372). (Formula Presented)
110. Habich, D.; Hartwig, W. Ger. Patent Appl. DE 3632916, Mar. 31, 1988 (Derwent WPI 88-092574).
111. (a) Shibata, T.; Sugimura, Y. J. Antibiotics 1989, 42, 374-381.
112. (b) Jap. Patent Appl. JP 62252786, Nov. 11, 1987 (Derwent WPI 87-351027 and 88-177669).
113. (a) Martel, A.; Daris, J.-P.; Bachand, C.; Corbeil, J.; Menard, M. Can. J. Chem., 1988, 66, 1537-1539.
114. (b) Martel, A; Bachand, C.; Menard, M. Eur. Patent Appl. EP 433759, Jun. 26, 1991 (Derwent WPI 91-186664).
115. (c) Corbeil, J.; Daris, J.P.; Martel, A. U.S. Patent US 4772683, Sep. 20, 1988 (Derwent WPI 88-285202).
116. (d) Martel, A; Daris, J.-P.; Corbeil, J. U.S. Patent US 4895939, Jan. 23, 1990 (Derwent WPI 90-083096).
117. Kim, C.U.; Luh, B.; Partyka, R.A. Tetrahedron Lett., 1987, 28, 507-510.
118. Endo, M. Can. J. Chem. 1987, 65, 2140-2145
119. Shibata, T.; Iino, K.; Tanaka, T.; Hashimoto, T.; Kameyama, Y.; Sugimura, Y. Tetrahedron Lett. 1985, 26, 4739-4742.
120. (a) Sasaki, A.; Matsumura, H.; Yano, T.; Takata, S.; Sunagawa, M. Chem. Pharm. Bull. 1992, 40, 1098-1104.
121. (b) Sunagawa, M.; Sasaki, A.; Goda, K. U.S. Patent US 5310897, May 10, 1994 (also Eur. Patent Appl. EP 188816, Jul. 30, 1986; Derwent WPI 86-198257).
122. (c) see also ref. 58.
123. (a) Fuentes, L.M.; Shinkai, I.; King, A.; Purick, R.; Reamer, R.A.; Scmitt, S.M.; Cama, L.; Christensen, B.G. J. Org. Chem. 1987, 52, 2563-2567.
124. Patents: (b) the overall process is claimed in U.S. Patent US 4595750, Jun. 17, 1986 (Derwent WPI 86-176238);
125. (c) compound claims to 174: Christensen, B.G.; Cama, Lovji, D.; Schmitt, S.M. U.S. Patent US 4873324, Oct. 10, 1989 (see also Eur. Patent Appl. EP 192171, Aug. 27, 1986) (Derwent WPI 86-226786);
126. (d) compound claims to iii: Shinkai, I.; King, A.O.; Fuentes, L.M. U.S. Patent US 5075436, Dec 24, 1991 (see also Eur. Patent Appl. EP 230792, Aug. 5, 1987) (Derwent WPI 87-215090);
127. (e) compound claims to 175: U.S. Patent US 4734497, Mar. 29, 1988 (see also Eur. Patent Appl. EP 192171, Aug. 27, 1986) (Derwent WPI 86-226786). (Formula Presented)
128. The Fuentes (Merck) and Meyers (Colorado State) groups both reported that the α-methyl isomer of 2 did not cyclize efficiently to the carbapenem nucleus (refs. 56 and 66).
129. Sunagawa, M.; Matsumura, H.; Yano, T.; Sasaki, A.; Takata, S. Eur. Patent Appl. EP 180189, May 7, 1986 (see also U.S. Patent US 5075435, Dec. 24, 1991; and U.S. Patent US 5112966, May 12, 1992; Derwent WPI 86-120367).
130. (a) Honda, T.; Wang, T.-C; Chu, S.-D. Chemistry Lett. 1990, 531-534.
131. (b) Honda, T. Jap. Patent Appl. JP 03157365, Jul. 5,1991 (assigned to Daiichi Pharmaceuticals; Derwent WPI 91-242282).
132. Rao, A.V.R.; Gurjar, M.K.; Khare, V.B.; Ashok, B.; Deshmukh, M.N. Tetrahedron Lett. 1990, 31, 271-274.
133. (a) Ohta, T.; Takaya, H.; Kitamura, M.; Nagai, K.; Noyori, R. J. Org. Chem. 1987, 52, 3174-3176.
134. (b) Jap. Patent Appl. JP 63290862, Nov. 11, 1988 (Derwent WPI 89-013373).
135. Kitamura, M.; Nagai, K.; Hsiao, Y.; Noyori, R. Tetrahedron Lett. 1990, 31, 529-532.
136. (a) Iimori, T.; Shibasaki, M. Tetrahedron Lett. 1986, 27, 2149-2152.
137. (b) Shibasaki, M.; Iimora, T. Eur. Patent Appl. EP 209886, Jan. 1, 1987 (Derwent WPI 87-023225).
138. (c) European Patent EP 224059, Jun. 3, 1987 (Derwent WPI 87-151608).
139. (d) Shibasaki, M.; Iimora, T.; Ishida, Y.; Terajima, A.; Kimura, Y. Jap. Patent Appl. JP 62230791, Oct. 9, 1987 (Derwent WPI 87-324537).
140. Christensen, B.C.; Shih, D.H. Eur. Patent Appl. EP 158101, Jul. 11, 1984 (Derwent WPI 84-172354).
141. Kaga, H.; Kobayashi, S.; Ohno, M. Tetrahedron Lett. 1989, 30, 113-116.
142. Sowin, T.J.; Meyers, A.I. J. Org. Chem. 1988, 53, 4154-4156.
143. (a) Bayles, R.; Flynn, A.P.; Galt, R.H.B.; Kirby, S.; Turner, R.W. Tetrahedron Lett. 1988, 48, 6341-6344.
144. (b) Bayles, R.; Flynn, A.P.; Galt, R.H.B.; Kirby, S.; Turner, R.W. Tetrahedron Lett. 1988, 48, 6345-6348.
145. Hatanaka, M. Tetrahedron Lett. 1987, 28, 83-86.
146. Udodong, U.E.; Fraser-Reid, B. J. Org. Chem. 1988, 53, 2131-2132.
147. (a) Matsumura, H.; Nozaki, Y.; Sunagawa, M. Chem. Pharm. Bull. 1994, 42, 2467-2741.
148. (b) Sunagawa, M.; Nozaki, Y.; Sasaki, A.; Matsumura, H. U.S. Patent US 5134231, Jul. 28, 1992 (also Eur. Patent Appl. EP 229384, Jul. 22, 1987; Derwent WPI 87-199939).
149. (a) Kawabata T.; Kimura, Y.; Ito, Y.; Terashima, S.; Sasaki, A.; Sunagawa, M. Tetrahedron 1988, 44, 2149-2165.
150. (b) Preliminary report: Kawabata T.; Kimura, Y.; Ito, Y.; Terashima, S.; Sasaki, A.; Sunagawa, M. Tetrahedron Lett 1986, 27, 6241-6244.
151. (c) Patent: Jap. Patent Appl. JP 62174048, Jul. 30, 1987 (Derwent WPI 87-253312).
152. Ihara, M.; Takahashi, M.; Fukumoto, K.; Kametani, T. J. Chem. Soc., Chem. Commun. 1988, 9-10.
153. (a) Ihara, M.; Takahashi, M.; Fukumoto, K. Heterocycles 1988, 27, 327-330.
154. (b) Kametani, T. Jap. Patent Appl. JP 63068577, Mar. 28, 1988 (assigned to Daiichi Seiyaku; Derwent WPI 88-123679).
155. (a) Ito, Y. Kimura, Y.; Terashima, S. Bull. Chem. Soc. Jap. 1987, 60, 3337-3340;
156. (b) Terashima, S.; Kimura, Y.; Ito, Y.; Sakai, K.; Hiyama, T. U.S. Patent US 4892961, Jan. 9, 1990 (Derwent WPI 87-030880).
157. Shirai, F.; Nakai, T. Tetrahedron Lett. 1988, 29, 6461-6464.
158. The reported yield for the reaction of 282 to 201 improved from 71% in ref. 75 to 81% in ref. 77, even though the conditions reported were identical.
159. Shirai, F.; Nakai, T. Chemistry Lett. 1989, 445-448.
160. Tsukada, N.; Shimada, T.; Gyoung, Y.S.; Asao, N.; Yamamoto, Y. J. Org. Chem. 1995, 60, 143-148.
161. Fliri, H.; Mak, C.-P. J. Org. Chem. 1985, 50, 3438-3442.
162. 4 and reported a 90% yield of 2;
163. (b) Jap. Patent Appl. JP 04368365, Dec. 21, 1992 (Derwent WPI 93-041752);
164. 4 in aqueous acetone and obtained an 80% yield of 2.
165. Jap. Patent Appl. JP 63112558, May 17, 1988 (Derwent WPI 88-173040).
166. Kanefaguchi Kagaku Kogyo, Jap. Patent Appl. JP 06287197, Nov. 10, 1994 (Derwent WPI 94-363562).
167. Haruta, J.; Nishi, K.; Kikuchi, K.; Matsuda, S.; Tamura, Y.; Kita, Y. Chem. Pharm. Bull. 1989, 37, 2338-2343.
168. Uyeo, S.; Itani, H. Tetrahedron Lett. 1991, 32, 2143-2144.
169. Prasad, J.S.; Liebeskind, L.S. Tetrahedron Lett. 1987, 28, 1857-1860.
170. cf. very similar compounds in Scheme 8 (ref. 17), Scheme 9 (ref. 19), and other citations in reference 18, which cited Baeyer-Villiger oxidations of C-4 methyl ketones to 1.
171. Miura, T.; Murayama, T.; Yoshida, A.; Kobayashi, T. Eur. Patent Appl. EP 546742, Jun. 16, 1993 (Derwent WPI 93-190102).
172. Choi, W.-B.; Churchill, H.R.O.; Lynch, J.E.; Thompson, A.S.; Humphrey, G.R.; Volante, R.P.; Reider, P.J.; Shinkai, I. Tetrahedron Lett. 1994, 35, 2275-2278.
173. Saito, T.; Matsamura, K.; Kato, Y.; Sayo, N.; Kumobayashi, H. Eur. Patent Appl. EP 614903, Sep. 14, 1994.